Metformin sustained-release tablets are mainly used to treat type 2 diabetes. They have no definite effect on weight loss and are not recommended to be used solely for weight loss. The main function of metformin sustained-release tablets is to control blood sugar levels by inhibiting the output of liver glycogen and increasing the sensitivity of surrounding tissues to insulin, thereby reducing blood sugar levels. Mild weight loss may occur in some patients, usually related to gastrointestinal reactions leading to decreased appetite, but overall weight changes are not significant. As a hypoglycemic drug, the primary goal of metformin sustained-release tablets is to stabilize blood sugar levels, not to lose weight. The drug instructions do not list weight loss as an indication, and healthy individuals using the drug may experience adverse reactions such as diarrhea and nausea.

diabetes patients may have slight weight loss when taking metformin sustained-release tablets, which is related to the hypoglycemic mechanism of the drug. But this phenomenon cannot be equated with professional weight loss effects, and weight changes are usually only more noticeable in the early stages of treatment. Clinical data shows that patients who use metformin sustained-release tablets for a long time have smaller weight changes and larger individual differences. People with weight loss needs should control their weight through scientific methods such as adjusting their diet structure and adhering to moderate exercise. It is not recommended to take hypoglycemic drugs indiscriminately. If medication is needed to intervene in obesity, regular weight loss drugs should be selected under the guidance of a doctor. Patients with diabetes and obesity should also follow the doctor's advice to use drugs in a standardized manner, and should not increase the dose of metformin sustained-release tablets to achieve weight loss.


Comments (0)
Leave a Comment
No comments yet
Be the first to share your thoughts!